129 related articles for article (PubMed ID: 32801739)
1. WHSC1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Activating mTORC1 Signaling.
Dai J; Jiang L; Qiu L; Shao Y; Shi P; Li J
Onco Targets Ther; 2020; 13():7033-7044. PubMed ID: 32801739
[TBL] [Abstract][Full Text] [Related]
2. KIAA1522 Promotes the Progression of Hepatocellular Carcinoma via the Activation of the Wnt/β-Catenin Signaling Pathway.
Jiang S; Zhang Y; Li Q; Qiu L; Bian B
Onco Targets Ther; 2020; 13():5657-5668. PubMed ID: 32606779
[TBL] [Abstract][Full Text] [Related]
3. BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway.
Qiu J; Zhang S; Wang P; Wang H; Sha B; Peng H; Ju Z; Rao J; Lu L
Cancer Med; 2020 Nov; 9(21):8159-8172. PubMed ID: 32977361
[TBL] [Abstract][Full Text] [Related]
4. WHSC1 acts as a prognostic indicator and functions as an oncogene in cervical cancer.
Wu J; Luo M; Duan Z; Jia Y; Linghu H; Tian P; Qi H
Onco Targets Ther; 2019; 12():4683-4690. PubMed ID: 31354300
[No Abstract] [Full Text] [Related]
5. WHSC1 promotes wnt/β-catenin signaling in a FoxM1-dependent manner facilitating proliferation, invasion and epithelial-mesenchymal transition in breast cancer.
Zhang J; Lu J; Chen Y; Li H; Lin L
J Recept Signal Transduct Res; 2020 Oct; 40(5):410-418. PubMed ID: 32314642
[No Abstract] [Full Text] [Related]
6. Piezo1 promoted hepatocellular carcinoma progression and EMT through activating TGF-β signaling by recruiting Rab5c.
Li YM; Xu C; Sun B; Zhong FJ; Cao M; Yang LY
Cancer Cell Int; 2022 Apr; 22(1):162. PubMed ID: 35461277
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
8. WHSC1 is involved in DNA damage, cellular senescence and immune response in hepatocellular carcinoma progression.
Yan J; Zhang MY; Lin J; Li KX; Zhao ZM; Gao YM; Deng XL; Wang CS; Wang HS
J Cell Mol Med; 2023 May; 27(10):1436-1441. PubMed ID: 37073435
[TBL] [Abstract][Full Text] [Related]
9. P4HB promotes HCC tumorigenesis through downregulation of GRP78 and subsequent upregulation of epithelial-to-mesenchymal transition.
Xia W; Zhuang J; Wang G; Ni J; Wang J; Ye Y
Oncotarget; 2017 Jan; 8(5):8512-8521. PubMed ID: 28052026
[TBL] [Abstract][Full Text] [Related]
10. Collagen Type X Alpha 1 (COL10A1) Contributes to Cell Proliferation, Migration, and Invasion by Targeting Prolyl 4-Hydroxylase Beta Polypeptide (P4HB) in Breast Cancer.
Yang W; Wu X; Zhou F
Med Sci Monit; 2021 Feb; 27():e928919. PubMed ID: 33637669
[TBL] [Abstract][Full Text] [Related]
11. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY
Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003
[TBL] [Abstract][Full Text] [Related]
12. MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence.
Liu M; Hu Q; Tu M; Wang X; Yang Z; Yang G; Luo R
J Exp Clin Cancer Res; 2018 Jan; 37(1):10. PubMed ID: 29357919
[TBL] [Abstract][Full Text] [Related]
13. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.
Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA
Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of EGFL8 regulates migration, invasion and apoptosis of hepatocellular carcinoma through activating Notch signaling pathway.
Wu F; Zhang FY; Tan GQ; Chen WJ; Huang B; Yan L; Zhang HL; Chen S; Jiao Y; Wang BL
BMC Cancer; 2021 Jun; 21(1):704. PubMed ID: 34130659
[TBL] [Abstract][Full Text] [Related]
15. WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck.
Saloura V; Cho HS; Kiyotani K; Alachkar H; Zuo Z; Nakakido M; Tsunoda T; Seiwert T; Lingen M; Licht J; Nakamura Y; Hamamoto R
Mol Cancer Res; 2015 Feb; 13(2):293-304. PubMed ID: 25280969
[TBL] [Abstract][Full Text] [Related]
16. The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation.
Kojima M; Sone K; Oda K; Hamamoto R; Kaneko S; Oki S; Kukita A; Machino H; Honjoh H; Kawata Y; Kashiyama T; Asada K; Tanikawa M; Mori-Uchino M; Tsuruga T; Nagasaka K; Matsumoto Y; Wada-Hiraike O; Osuga Y; Fujii T
BMC Cancer; 2019 May; 19(1):455. PubMed ID: 31092221
[TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNA LINC01134 Promotes Hepatocellular Carcinoma Metastasis via Activating AKT1S1 and NF-κB Signaling.
Wang C; Chen Y; Chen K; Zhang L
Front Cell Dev Biol; 2020; 8():429. PubMed ID: 32656205
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic activation of WHSC1 functions as an oncogene and is associated with poor prognosis in cervical cancer.
Yin Z; Sun Y; Ge S; Sun J
Oncol Rep; 2017 Apr; 37(4):2286-2294. PubMed ID: 28260054
[TBL] [Abstract][Full Text] [Related]
19. Wolf-Hirschhorn Syndrome Candidate 1 (whsc1) Functions as a Tumor Suppressor by Governing Cell Differentiation.
Yu C; Yao X; Zhao L; Wang P; Zhang Q; Zhao C; Yao S; Wei Y
Neoplasia; 2017 Aug; 19(8):606-616. PubMed ID: 28654864
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
